NCT04167995View on ClinicalTrials.gov

Assessment of Probiotics Lactobacillus in the Management of Attention Deficit Hyperactive Disorder

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 9, 2020

Primary Completion Date

November 9, 2020

Study Completion Date

October 30, 2021

Conditions
InattentiveHyperactivityImpulsivity
Interventions
DRUG

Probiotic Formula lacteal forte

Active Comparator: Patient with attention deficit hyperactive disorder patients (n=40) will receive probiotic preparation twice daily (Lacteol Forte; Rameda, Egypt) as sachets containing 10 billion colony forming units (CFU) of Lactobacillus fermentum and Lactobacillus delbruekii for 12 weeks .

Trial Locations (1)

11757

Reham Ibrahim, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04167995 - Assessment of Probiotics Lactobacillus in the Management of Attention Deficit Hyperactive Disorder | Biotech Hunter | Biotech Hunter